Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Outcomes and Surgical Interventions for Patients with Intestinal Metastases from Advanced Epithelial Ovarian Cancer

  • By

  • Hongxia Wang

  • Yijie Li

  • Zhifen Yang

  • Jinxiu Wang

  • Kaiyun Qin

  • Yu Yu

  • Na Wang

  • Jingde Jia

  • Wenhong Zhao

  • Fenghua Zhang

  • Mario M. Leitao

  • Ran Meng

  • Yueping Liu

  • Yan Ding

  • Zhengmao Zhang

  • August 13, 2026

Share

  • 1

    A correction was made to inaccuracies in Table 1 regarding FIGO Stages for ovarian cancer.

  • 2

    The term 'Other' in Table 1 was corrected to align with the formatting of 'Endometrioid'.

  • 3

    An amendment in the Materials and methods section corrected '3orksycles' to '3–4 cycles'.

  • 4

    Patients began a liquid diet three days before surgery, with oral laxatives administered one day prior.

  • 5

    Neoadjuvant chemotherapy is indicated for patients with advanced ovarian cancer unable to undergo immediate surgery.

Original Source(s)

Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer

  • by Hongxia Wang, Yijie Li, Zhifen Yang, Jinxiu Wang, Kaiyun Qin, Yu Yu, Na Wang, Jingde Jia, Wenhong Zhao, Fenghua Zhang, Mario M. Leitao, Ran Meng, Yueping Liu, Yan Ding, Zhengmao Zhang

  • August 13, 2026

Related Content

Case Report: Diagnosis and treatment report and literature review of 2 cases of VHL-deficient renal cell carcinoma

Non-anticoagulant heparins: glycan-mediated immune modulation and therapeutic applications

Correction: Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

  • August 1, 2026